\-\ Texto\\:\\ \ \(0\)\
\-\ examination\\:\\ \ \(12\)\
\-\ scalp\\:\\ diffuse\\ nonscarring\\ alopecia\\,\\ erythema\\ and\\ fine\\ scales\ \(0\)\
\-\ face\\:\\ heliotrope\\ eruption\\ on\\ eyelids\ \(0\)\
\-\ arms\\:\\ large\\ violacious\\ lichenified\\ plaques\\ in\\ a\\ photo\\-\ \(0\)\
\-\ distrubution\ \(1\)\
\-\ back\\:\\ diffuse\\ erythematous\\ patch\\ in\\ a\\ shawl\\-like\\ distribution\ \(0\)\
\-\ hands\\:\\	erythematous\\ extensor\\ tendon\\ plaques\\;\\ gottron\\'s\ \(0\)\
\-\ papules\\ over\\ mcp\\ and\\ pip\\ joints\\ \ \(0\)\
\-\ fingernails\\:\\ proximal\\ nail\\ folds\\ with\\ dilated\\ and\\ tortuous\\ capillaries\\ with\\ dropout\\ and\\ ragged\\ cuticles\ \(0\)\
\-\ legs\\:\\ violaceous\\ plaques\\ on\\ knees\\ and\\ extensor\\ thighs\ \(0\)\
\-\ therapeutic\\ trials\\ in\\ the\\ past\\ with\\ prednisone\\,\\ cyclosporine\\,\\ accutane\\,\\ plaquenil\\,\\ and\\ methotrexate\\ were\\ discontinued\\ secondary\\ to\\ adverse\\ effects\\ \\(i\\.e\\ recurrent\\ transaminitis\\)\\.\\ from\\ january\\ 1996\\ to\\ december\\ 2001\\ monthly\\ ivig\\ stabilized\\ her\\ disease\\ activity\\.\\ she\\ started\\ etanercept\\ injections\\ in\\ december\\ 2001\\ and\\ has\\ had\\ significantly\\ decreased\\ exacerbations\\ of\\ her\\ muscle\\ disease\\.\\ she\\ is\\ followed\\ closely\\ by\\ gyn\\ and\\ had\\ a\\ normal\\ gynecologic\\ exam\\,\\ mammogram\\,\\ chest\\ x\\-ray\\,\\ and\\ screening\\ colonoscopy\\ in\\ 2002\\.\ \(0\)\
\-\ labs\\:\\ ana\\ positive\\ 1\\:320\\ speckled\\;\\ anti\\-rnp\\,\\ anti\\-smith\\,\\ anti\\-ro\\/la\\,\\ anti\\-jo\\ antibodies\\ negative\\;\\ mri\\ of\\ lower\\ extremities\\ demonstrated\\ extensive\\ atrophy\\ with\\ minimal\\ inflammation\\;\\ emg\\ consistant\\ with\\ myopathic\\ disease\\;\\ history\\ of\\ slightly\\ elevated\\ ck\\ and\\ aldolase\\ when\\ symptomatic\\;\\ hepatitis\\ panel\\ negative\\.\ \(0\)\
\-\ histopathology\\:\\ the\\ biopsy\\ shows\\ epidermal\\ atrophy\\ with\\ compact\\ orthokeratotic\\ hyperkeratosis\\,\\ focal\\ vacuolar\\ interface\\ dermatitis\\,\\ dilated\\ vessels\\,\\ and\\ an\\ increase\\ in\\ dermal\\ interstitial\\ mucin\\.\ \(0\)\
\-\ case\\ 5\\,\\ \\(27th\\ annual\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ 2003\\)\\ dermatomyositis\ \(0\)\
\-\ \\â\\€\\¢\\ sle\ \(0\)\
\-\ \\â\\€\\¢rosacea\ \(1\)\
\-\ \\â\\€\\¢drug\\ eruption\ \(1\)\
\-\ history\\:\\ a\\ 55\\ year\\ old\\ caucasian\\ female\\ with\\ a\\ nine\\ year\\ history\\ of\\ dermatomyositis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ plaques\\:\\ 0\\.05342313980744718\ \(0\)\
\-\ eruption\\:\\ 0\\.04860398008188397\ \(0\)\
\-\ dermatomyositis\\:\\ 0\\.04724337144909326\ \(0\)\
\-\ \\:\\:\\ 0\\.04639187677573625\ \(0\)\
\-\ \\;\\:\\ 0\\.04534525048774463\ \(0\)\
\-\ december\\:\\ 0\\.04464406776052449\ \(0\)\
\-\ extensor\\:\\ 0\\.038447438640573525\ \(0\)\
\-\ erythematous\\:\\ 0\\.03705500613624209\ \(0\)\
\-\ 2001\\:\\ 0\\.033872032126495845\ \(0\)\
\-\ atrophy\\:\\ 0\\.03290148639330034\ \(0\)\
\-\ nonscarring\\:\\ 0\\.03289372546256156\ \(0\)\
\-\ violacious\\:\\ 0\\.03289372546256156\ \(0\)\
\-\ lichenified\\:\\ 0\\.03289372546256156\ \(0\)\
\-\ photo\\-\\:\\ 0\\.03289372546256156\ \(0\)\
\-\ distrubution\\:\\ 0\\.03289372546256156\ \(0\)\
\-\ shawl\\-like\\:\\ 0\\.03289372546256156\ \(0\)\
\-\ gottron\\'s\\:\\ 0\\.03289372546256156\ \(0\)\
\-\ 1\\:320\\:\\ 0\\.03289372546256156\ \(0\)\
\-\ myopathic\\:\\ 0\\.03289372546256156\ \(0\)\
\-\ orthokeratotic\\:\\ 0\\.03289372546256156\ \(0\)\
\-\ \\â\\€\\¢rosacea\\:\\ 0\\.03289372546256156\ \(0\)\
\-\ \\â\\€\\¢drug\\:\\ 0\\.03289372546256156\ \(0\)\
\-\ heliotrope\\:\\ 0\\.030307355385845346\ \(0\)\
\-\ cuticles\\:\\ 0\\.030307355385845346\ \(0\)\
\-\ accutane\\:\\ 0\\.030307355385845346\ \(0\)\
\-\ plaquenil\\:\\ 0\\.030307355385845346\ \(0\)\
\-\ ivig\\:\\ 0\\.030307355385845346\ \(0\)\
\-\ anti\\-rnp\\:\\ 0\\.030307355385845346\ \(0\)\
\-\ anti\\-ro\\/la\\:\\ 0\\.030307355385845346\ \(0\)\
\-\ anti\\-jo\\:\\ 0\\.030307355385845346\ \(0\)\
\-\ aldolase\\:\\ 0\\.030307355385845346\ \(0\)\
\-\ scales\\:\\ 0\\.02879442587797906\ \(0\)\
\-\ fingernails\\:\\ 0\\.02879442587797906\ \(0\)\
\-\ dropout\\:\\ 0\\.02879442587797906\ \(0\)\
\-\ transaminitis\\:\\ 0\\.02879442587797906\ \(0\)\
\-\ anti\\-smith\\:\\ 0\\.02879442587797906\ \(0\)\
\-\ etanercept\\:\\ 0\\.027720985309129132\ \(0\)\
\-\ compact\\:\\ 0\\.027720985309129132\ \(0\)\
\-\ vacuolar\\:\\ 0\\.027720985309129132\ \(0\)\
\-\ ragged\\:\\ 0\\.0268883601176582\ \(0\)\
\-\ speckled\\:\\ 0\\.0268883601176582\ \(0\)\
\-\ hyperkeratosis\\:\\ 0\\.0268883601176582\ \(0\)\
\-\ alopecia\\:\\ 0\\.026208055801262845\ \(0\)\
\-\ nail\\:\\ 0\\.026208055801262845\ \(0\)\
\-\ cyclosporine\\:\\ 0\\.025632866697429795\ \(0\)\
\-\ gynecologic\\:\\ 0\\.025632866697429795\ \(0\)\
\-\ eyelids\\:\\ 0\\.025134615232412918\ \(0\)\
\-\ violaceous\\:\\ 0\\.024695126293396562\ \(0\)\
\-\ capillaries\\:\\ 0\\.024301990040941985\ \(0\)\
\-\ exacerbations\\:\\ 0\\.024301990040941985\ \(0\)\
\-\ consistant\\:\\ 0\\.024301990040941985\ \(0\)\
\-\ monthly\\:\\ 0\\.023946355041672116\ \(0\)\
\-\ gyn\\:\\ 0\\.023946355041672116\ \(0\)\
\-\ ck\\:\\ 0\\.02362168572454663\ \(0\)\
\-\ thighs\\:\\ 0\\.023323018904869257\ \(0\)\
\-\ dilated\\:\\ 0\\.023172323929788272\ \(0\)\
\-\ trials\\:\\ 0\\.02304649662071358\ \(0\)\
\-\ adverse\\:\\ 0\\.02304649662071358\ \(0\)\
\-\ 2002\\.\\:\\ 0\\.02304649662071358\ \(0\)\
\-\ antibodies\\:\\ 0\\.02304649662071358\ \(0\)\
\-\ discontinued\\:\\ 0\\.0227890605330757\ \(0\)\
\-\ mucin\\:\\ 0\\.0227890605330757\ \(0\)\
\-\ stabilized\\:\\ 0\\.022322033880262247\ \(0\)\
\-\ dermatitis\\:\\ 0\\.02210875621668035\ \(0\)\
\-\ patch\\:\\ 0\\.02190701285373156\ \(0\)\
\-\ epidermal\\:\\ 0\\.02190701285373156\ \(0\)\
\-\ nine\\:\\ 0\\.02190701285373156\ \(0\)\
\-\ january\\:\\ 0\\.02171561996422577\ \(0\)\
\-\ ana\\:\\ 0\\.02171561996422577\ \(0\)\
\-\ pip\\:\\ 0\\.021533567112847294\ \(0\)\
\-\ 27th\\:\\ 0\\.021533567112847294\ \(0\)\
\-\ dermal\\:\\ 0\\.021359984964955902\ \(0\)\
\-\ papules\\:\\ 0\\.020736648828153043\ \(0\)\
\-\ mcp\\:\\ 0\\.020736648828153043\ \(0\)\
\-\ methotrexate\\:\\ 0\\.020329188783507552\ \(0\)\
\-\ tortuous\\:\\ 0\\.01996187507898049\ \(0\)\
\-\ 1996\\:\\ 0\\.01996187507898049\ \(0\)\
\-\ injections\\:\\ 0\\.01984705545708962\ \(0\)\
\-\ interface\\:\\ 0\\.019735663803546032\ \(0\)\
\-\ folds\\:\\ 0\\.019320642777015347\ \(0\)\
\-\ diffuse\\:\\ 0\\.019306025525188918\ \(0\)\
\-\ closely\\:\\ 0\\.019223719320286763\ \(0\)\
\-\ her\\:\\ 0\\.019174713869290563\ \(0\)\
\-\ negative\\:\\ 0\\.019045672846081153\ \(0\)\
\-\ emg\\:\\ 0\\.019037113273366383\ \(0\)\
\-\ sle\\:\\ 0\\.019037113273366383\ \(0\)\
\-\ prednisone\\:\\ 0\\.018859396672660206\ \(0\)\
\-\ panel\\:\\ 0\\.01877361488823969\ \(0\)\
\-\ effects\\:\\ 0\\.018607750102527625\ \(0\)\
\-\ colonoscopy\\:\\ 0\\.018607750102527625\ \(0\)\
\-\ knees\\:\\ 0\\.018527503068121044\ \(0\)\
\-\ fine\\:\\ 0\\.018372007932298026\ \(0\)\
\-\ hepatitis\\:\\ 0\\.018296624696038627\ \(0\)\
\-\ scalp\\:\\ 0\\.01800945663209785\ \(0\)\
\-\ therapeutic\\:\\ 0\\.017940989696768758\ \(0\)\
\-\ she\\:\\ 0\\.017901389115329642\ \(0\)\
\-\ arms\\:\\ 0\\.01780771326914906\ \(0\)\
\-\ histopathology\\:\\ 0\\.01780771326914906\ \(0\)\
\-\ seminar\\:\\ 0\\.01774281870679134\ \(0\)\
\-\ uniformed\\:\\ 0\\.017554643879825325\ \(0\)\
\-\ legs\\:\\ 0\\.017260685380373404\ \(0\)\
\-\ services\\:\\ 0\\.017204573897669898\ \(0\)\
\-\ dermatology\\:\\ 0\\.017204573897669898\ \(0\)\
\-\ i\\.e\\:\\ 0\\.01704113127581022\ \(0\)\
\-\ mammogram\\:\\ 0\\.01663734924357055\ \(0\)\
\-\ hands\\:\\ 0\\.016496527124231563\ \(0\)\
\-\ significantly\\:\\ 0\\.016316668535358885\ \(0\)\
\-\ \\,\\:\\ 0\\.016161794956255963\ \(0\)\
\-\ 2003\\:\\ 0\\.01602138002581141\ \(0\)\
\-\ annual\\:\\ 0\\.015981040786616576\ \(0\)\
\-\ erythema\\:\\ 0\\.015673126519124024\ \(0\)\
\-\ face\\:\\ 0\\.01563636421896353\ \(0\)\
\-\ disease\\:\\ 0\\.015635121730026538\ \(0\)\
\-\ interstitial\\:\\ 0\\.015599960581107696\ \(0\)\
\-\ 55\\:\\ 0\\.015457796975763402\ \(0\)\
\-\ caucasian\\:\\ 0\\.015221343192432846\ \(0\)\
\-\ tendon\\:\\ 0\\.014877629427851482\ \(0\)\
\-\ joints\\:\\ 0\\.014590461363910704\ \(0\)\
\-\ x\\-ray\\:\\ 0\\.014375648483979816\ \(0\)\
\-\ distribution\\:\\ 0\\.014349645986531706\ \(0\)\
\-\ started\\:\\ 0\\.014222284022466563\ \(0\)\
\-\ had\\:\\ 0\\.013760073277915733\ \(0\)\
\-\ screening\\:\\ 0\\.013600874734807263\ \(0\)\
\-\ inflammation\\:\\ 0\\.013558712215203035\ \(0\)\
\-\ recurrent\\:\\ 0\\.013455344295242826\ \(0\)\
\-\ increase\\:\\ 0\\.013374663459372804\ \(0\)\
\-\ history\\:\\ 0\\.013211356765377798\ \(0\)\
\-\ slightly\\:\\ 0\\.01288890394872042\ \(0\)\
\-\ vessels\\:\\ 0\\.012836716478665421\ \(0\)\
\-\ extensive\\:\\ 0\\.012751327322569945\ \(0\)\
\-\ symptomatic\\:\\ 0\\.012667848599605269\ \(0\)\
\-\ minimal\\:\\ 0\\.012554029740301485\ \(0\)\
\-\ extremities\\:\\ 0\\.012506293354257045\ \(0\)\
\-\ activity\\:\\ 0\\.011962860555154994\ \(0\)\
\-\ muscle\\:\\ 0\\.011452668781441586\ \(0\)\
\-\ biopsy\\:\\ 0\\.01131228821506254\ \(0\)\
\-\ labs\\:\\ 0\\.011089455249757978\ \(0\)\
\-\ elevated\\:\\ 0\\.010818344631936802\ \(0\)\
\-\ followed\\:\\ 0\\.010689835340965565\ \(0\)\
\-\ back\\:\\ 0\\.010518904236371184\ \(0\)\
\-\ positive\\:\\ 0\\.010346588023448197\ \(0\)\
\-\ past\\:\\ 0\\.010131341313232962\ \(0\)\
\-\ examination\\:\\ 0\\.009912026251770767\ \(0\)\
\-\ proximal\\:\\ 0\\.009572922319802295\ \(0\)\
\-\ decreased\\:\\ 0\\.009480434338524475\ \(0\)\
\-\ in\\:\\ 0\\.009434266346423617\ \(0\)\
\-\ demonstrated\\:\\ 0\\.009356044710660327\ \(0\)\
\-\ 5\\:\\ 0\\.009328956800164788\ \(0\)\
\-\ when\\:\\ 0\\.009131832976179125\ \(0\)\
\-\ focal\\:\\ 0\\.009106319418426873\ \(0\)\
\-\ secondary\\:\\ 0\\.008914290919808983\ \(0\)\
\-\ shows\\:\\ 0\\.008766319775107756\ \(0\)\
\-\ over\\:\\ 0\\.00811806936619389\ \(0\)\
\-\ chest\\:\\ 0\\.007629585821110144\ \(0\)\
\-\ a\\:\\ 0\\.007399250033929127\ \(0\)\
\-\ and\\:\\ 0\\.007388429339755235\ \(0\)\
\-\ mri\\:\\ 0\\.007325656175054551\ \(0\)\
\-\ were\\:\\ 0\\.007239874390634034\ \(0\)\
\-\ lower\\:\\ 0\\.0071711271244920246\ \(0\)\
\-\ year\\:\\ 0\\.007135113949797871\ \(0\)\
\-\ exam\\:\\ 0\\.007004604253543052\ \(0\)\
\-\ case\\:\\ 0\\.006975762809206234\ \(0\)\
\-\ large\\:\\ 0\\.0069721732531010435\ \(0\)\
\-\ female\\:\\ 0\\.006555075639730722\ \(0\)\
\-\ has\\:\\ 0\\.005987686457068201\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.005847068476104059\ \(0\)\
\-\ on\\:\\ 0\\.005402171734070359\ \(0\)\
\-\ \\(\\:\\ 0\\.005390759151073586\ \(0\)\
\-\ \\)\\:\\ 0\\.005324908150099291\ \(0\)\
\-\ by\\:\\ 0\\.005309219788227145\ \(0\)\
\-\ normal\\:\\ 0\\.004998553935071272\ \(0\)\
\-\ from\\:\\ 0\\.004725506392366464\ \(0\)\
\-\ an\\:\\ 0\\.004409197254793768\ \(0\)\
\-\ old\\:\\ 0\\.0032646813315755766\ \(0\)\
\-\ to\\:\\ 0\\.0031870754361416885\ \(0\)\
\-\ with\\:\\ 0\\.0030560792262284632\ \(0\)\
\-\ is\\:\\ 0\\.0020980999193459912\ \(0\)\
\-\ of\\:\\ 0\\.0017388626984774392\ \(0\)\
\-\ the\\:\\ 0\\.0010317110798778045\ \(0\)\
\-\ \\.\\:\\ 0\\.0007947657335226777\ \(0\)\
